Zheng Y, Bergold A, Duffel M W
Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City 52242.
J Biol Chem. 1994 Dec 2;269(48):30313-9.
2'-O-[(R)-Formyl(adenin-9-yl)-methyl]-(S)-glyceraldehyde 3'-triphosphate (also designated as ATP dialdehyde or ATPDA) was utilized as an affinity label for the 3'-phosphoadenosine 5'-phosphosulfate (PAPS) binding site of an aryl sulfotransferase. The sulfotransferase employed in these studies was rat hepatic aryl sulfotransferase (AST) IV (also known as tyrosine-ester sulfotransferase, EC 2.8.2.9), for which a cDNA had been previously cloned and expressed in Escherichia coli and the resulting enzyme purified to homogeneity. ATPDA was a time-dependent irreversible inhibitor of the recombinant AST IV, and this inhibition was prevented by including either PAPS or adenosine 3',5'-diphosphate (PAP) in the incubation of AST IV with ATPDA. Experiments relating covalent binding of [2,8-3H]ATPDA with catalytic activity indicated that 1 nmol of the affinity label was bound per nmol of AST IV subunit. Incubation of [2,8-3H]ATPDA with the enzyme followed by reduction with sodium cyanoborohydride, proteolysis with trypsin, and separation of the resulting peptides by high pressure liquid chromatography yielded two labeled peptide fractions. Automated sequence analysis showed that both modified peptide fractions were derived from the same sequence in AST IV: 63-Leu-Glu-Lys-Cys-Gly-Arg-68. Both the sequencing results and examination of the two peptide fractions by matrix-assisted laser desorption ionization mass spectrometry indicated that the ATPDA affinity label was bound to the hexapeptide at both lysine 65 and cysteine 66. These affinity labeled amino acids are located within a region of sequence in AST IV that shows considerable homology with various sulfotransferases that possess diverse specificities for acceptor substrates, and this may provide insight into PAPS binding in other sulfotransferases.
2'-O-[(R)-甲酰基(腺嘌呤-9-基)-甲基]-(S)-甘油醛3'-三磷酸(也称为ATP二醛或ATPDA)被用作芳基磺基转移酶3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)结合位点的亲和标记物。这些研究中使用的磺基转移酶是大鼠肝脏芳基磺基转移酶(AST)IV(也称为酪氨酸酯磺基转移酶,EC 2.8.2.9),其cDNA先前已被克隆并在大肠杆菌中表达,所得酶被纯化至同质。ATPDA是重组AST IV的时间依赖性不可逆抑制剂,并且通过在AST IV与ATPDA的孵育中加入PAPS或腺苷3',5'-二磷酸(PAP)可防止这种抑制。将[2,8-3H]ATPDA的共价结合与催化活性相关的实验表明,每nmol AST IV亚基结合1 nmol的亲和标记物。将[2,8-3H]ATPDA与该酶孵育,然后用氰基硼氢化钠还原,用胰蛋白酶进行蛋白水解,并通过高压液相色谱分离所得肽,得到两个标记的肽级分。自动序列分析表明,两个修饰的肽级分均源自AST IV中的相同序列:63-亮氨酸-谷氨酸-赖氨酸-半胱氨酸-甘氨酸-精氨酸-68。测序结果以及通过基质辅助激光解吸电离质谱对两个肽级分的检查均表明,ATPDA亲和标记物在赖氨酸65和半胱氨酸66处均与六肽结合。这些亲和标记的氨基酸位于AST IV的一个序列区域内,该区域与对受体底物具有不同特异性的各种磺基转移酶显示出相当的同源性,这可能有助于深入了解其他磺基转移酶中的PAPS结合。